The ICM+ AI model demonstrated superior prognostic value for breast cancer recurrence compared to Oncotype DX, especially for late distant recurrences. Integration of pathomic imaging in the ICM+ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback